Mid-Career Mentoring Award For Patient-Oriented Research in Frailty and Health Outcomes
职业生涯中期指导奖,表彰以患者为导向的虚弱和健康结果研究
基本信息
- 批准号:10448534
- 负责人:
- 金额:$ 17.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:AcademyAcuteAdoptedAdoptionAffectAgeAgingAwardCardiologyCaringClinicalClinical ManagementClinical ResearchComplexDataData ScientistData SourcesDiseaseElderlyEnvironmentEpidemiologistEpidemiologyFacultyFellowshipFosteringFundingFutureGeriatricsGoalsGrantGrowthHealthHealth PolicyHealth Services ResearchHealth StatusHealth systemHealthcare SystemsHeterogeneityIndividualInstitutesInstitutionK-Series Research Career ProgramsLeadershipLearningLinkMeasurementMedicalMedicareMedicineMentorsMentorshipMethodologyMid-Career Clinical Scientist Award (K24)MissionNational Institute on AgingOperative Surgical ProceduresOutcomePaperPatientsPeer ReviewPersonsPharmacoepidemiologyPharmacotherapyPhysiologicalPilot ProjectsPopulationPrimary Health CareProliferatingPublic HealthPublishingReportingResearchResearch ActivityResearch MethodologyResearch PersonnelResearch Project GrantsResourcesStudentsSurgical SpecialtiesTrainingTraining ProgramsTranslatingWritingbasecareercareer developmentclinical decision-makingcollaborative environmentfeasibility testingfrailtyfunctional outcomeshuman old age (65+)implementation scienceimprovedindexingindividual patientindividualized medicineinter-individual variationmedical specialtiesolder patientpatient oriented researchpersonalized carepersonalized medicineprogramsresponsible research conductskillsstandard of carestressortreatment effecttreatment responsetrend
项目摘要
PROJECT SUMMARY
Increasing evidence suggests that frailty—a common problem of old age characterized by reduced physiologic
reserve and inability to tolerate acute stressors—may determine inter-individual variability in outcomes after drug
therapy and surgical procedures among older adults. While this understanding supports the idea of personalizing
treatments based on a patient's frailty level, there is little empirical evidence on how to use frailty information to
maximize benefits or avoid harms in older patients. There is a pressing need to understand how frailty affects
the outcomes of various medical and surgical treatments. The candidate is a geriatrician and epidemiologist
who has established a robust patient-oriented research program on frailty, geriatric pharmacoepidemiology, and
prediction of functional outcomes after surgery at Hebrew SeniorLife Marcus Institute for Aging Research. He is
also a dedicated mentor of trainees and junior faculty, who have published a number of peer-reviewed papers
and have successfully competed for training and career development awards in aging research. The candidate's
research program has a long-term objective to improve care of older adults with frailty by generating high-quality
evidence, training future clinicians and researchers, and changing health systems and policy. Toward this goal,
his current NIA-funded research focuses on use of a frailty index for Medicare data to determine who should be
treated with a drug therapy or a surgical procedure and who should not due to lack of benefit or increased
likelihood of harm. This K24 Mid-career Investigator Award proposal will allow the candidate to develop a formal
mentoring program, expand his research, and become a more effective mentor and leader. The specific aims
are to: 1) develop a mentoring program in frailty research for early-stage and new investigators from diverse
clinical and research backgrounds; 2) conduct high-quality research to determine heterogeneity of treatment
effects by frailty for a broad range of medical and surgical interventions; and 3) acquire new research skills in
implementation science and enhance capacity in mentorship and leadership within and outside geriatrics. The
outstanding collaborative environment of Hebrew SeniorLife and other Harvard-affiliated institutions will provide
resources (e.g., various data sources, including Medicare data, computing environment, and career development
training courses) and support (e.g., data scientists and research methodology experts) needed to accomplish
the proposed activities. The advancement of the candidate's mentoring and research program, supported by
this K24 award, will foster growth of well-trained clinician investigators in aging research and accelerate adoption
of personalized medicine for older adults across medical and surgical specialties based on a patient's frailty level.
项目摘要
越来越多的证据表明,脆弱-一个常见的问题,老年人的特点是减少生理
储备和无法忍受急性应激-可能决定个体间的差异,在药物治疗后,
治疗和外科手术在老年人。虽然这种理解支持个性化的想法,
尽管基于患者的虚弱程度进行治疗,但关于如何使用虚弱信息来
最大限度地提高老年患者的获益或避免伤害。我们迫切需要了解脆弱是如何影响
各种医疗和手术治疗的结果。候选人是一位老年病学家和流行病学家
世卫组织建立了一个强大的以患者为导向的研究项目,涉及虚弱、老年药物流行病学和
希伯来老年生活马库斯老龄研究所手术后的功能结果预测。他是
也是一个专门的导师的学员和初级教师,谁发表了一些同行评议的论文
并成功地竞争了老龄化研究方面的培训和职业发展奖。候选人的
一项研究计划的长期目标是通过产生高质量的
证据,培训未来的临床医生和研究人员,改变卫生系统和政策。为了实现这一目标,
他目前的研究重点是使用医疗保险数据的脆弱指数,以确定谁应该
接受药物治疗或外科手术治疗的患者,由于缺乏获益或增加
伤害的可能性。这个K24职业中期研究者奖提案将允许候选人制定一个正式的
导师计划,扩大他的研究,并成为一个更有效的导师和领导者。具体目标
是:1)制定一个指导计划,在脆弱性研究的早期阶段和新的调查人员从不同的
临床和研究背景; 2)进行高质量的研究,以确定治疗的异质性
脆弱的影响,为广泛的医疗和外科干预措施;和3)获得新的研究技能,
实施科学和加强老年医学内外指导和领导能力。的
希伯来SeniorLife和其他哈佛附属机构的杰出合作环境将提供
资源(例如,各种数据源,包括Medicare数据、计算环境和职业发展
培训课程)和支持(例如,数据科学家和研究方法专家),
拟议的活动。候选人的指导和研究计划的进步,由
这项K24奖将促进老龄化研究中训练有素的临床研究人员的成长,并加速采用
根据患者的虚弱程度,为医疗和外科专业的老年人提供个性化医疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dae Hyun Kim其他文献
Dae Hyun Kim的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dae Hyun Kim', 18)}}的其他基金
Mid-Career Mentoring Award For Patient-Oriented Research in Frailty and Health Outcomes
职业生涯中期指导奖,表彰以患者为导向的虚弱和健康结果研究
- 批准号:
10651807 - 财政年份:2022
- 资助金额:
$ 17.25万 - 项目类别:
Applications of Claims-Based Frailty Index to Advance Evidence for Frailty-Guided Decision-Making
应用基于索赔的衰弱指数为衰弱指导决策提供证据
- 批准号:
10297953 - 财政年份:2021
- 资助金额:
$ 17.25万 - 项目类别:
Applications of Claims-Based Frailty Index to Advance Evidence for Frailty-Guided Decision-Making
应用基于索赔的衰弱指数为衰弱指导决策提供证据
- 批准号:
10640938 - 财政年份:2021
- 资助金额:
$ 17.25万 - 项目类别:
Prospective Monitoring of Newly Approved Cardiovascular Drugs in Older Adults with Frailty
新批准的心血管药物对虚弱老年人的前瞻性监测
- 批准号:
10338082 - 财政年份:2019
- 资助金额:
$ 17.25万 - 项目类别:
Epidemiology and Risk of Antipsychotic Use in Hospitalized Elderly with Delirium
患有谵妄的住院老年人的流行病学和使用抗精神病药物的风险
- 批准号:
9980746 - 财政年份:2018
- 资助金额:
$ 17.25万 - 项目类别:
Development and Validation of a Frailty Index Using Claims Data for Pharmacoepidemiologic Studies in Older Adults
使用老年人药物流行病学研究的索赔数据开发和验证虚弱指数
- 批准号:
8966383 - 财政年份:2015
- 资助金额:
$ 17.25万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 17.25万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 17.25万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 17.25万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 17.25万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 17.25万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 17.25万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 17.25万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 17.25万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 17.25万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 17.25万 - 项目类别:
Standard Grant